Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 87
2

Update on our progress using PET/CT

We want to update our supports and backers on our progress that was made possible through your kind donations to our laboratory. We now have the PET/CT up and running and have started to use this powerful new technology to generate data. In this first pilot experiment, we used an 18F-NaF radioactive probe to label bone in a mouse (the blue color). We then used the PET to measure the radioactive signal (the blue color) and the CT (X-ray image) to generate a 3-dimensional reconstruction of the mouse (as seen in the video below). We will use this data to study a variety of pathologies and biological pathways of multiple myeloma engrafted in the bone marrow, as well as how different drugs can modify or regulate these systems in vivo. For example, we will use unique probes to carefully and systematically study changes in metabolism, blood flow, hypoxia, and pH in the myeloma tumors. We can also study how growth of the tumors impact on bone marrow function, the formation of bone lesions, and effects on tumor recruitment and migration. Finally, using these models, we can study how different anti-myeloma therapeutic strategies effect tumor cells using these powerful imaging technologies.

The donations provide by our backers have allowed us the purchase mice and reagents to continue our experiments. Thank you and we will keep you informed of our continuing progress.

Donations are still welcome.


2 comments

Join the conversation!Sign In
  • EssiHonkasalo
    EssiHonkasalo
    Well done!
    Aug 12, 2019
  • John Frost
    John FrostBacker
    Incredible technology Dr. Frost, keep up the research. Fondly, Mom
    May 05, 2016

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Urban Pollination: sustain native bees & urban crops

Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...

Cannibalism in Giant Tyrannosaurs

This is the key question we hope to answer with this study. This project is to fund research into a skull...

Seattle HiveBio Community Lab

Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...

Backer Badge Funded

Add a comment